|
|
 |
|
Viewing report
|
|
|
|
Opportunities in R&D 2001
Business Insights, Aug 2001
The new report, Opportunities in R&D 2001 provides a concise strategic analysis of key issues in the realm of drug development. This report will enable you to Identify the unmet need in age-related diseases, Maximise market opportunity through alternative drug delivery and dosage regimens, Quantify the commercial benefits of the reduced development time associated with botanicals, Gain an insight into the ethical concerns surrounding IP rights and bioprospecting , Understand the benefits of developing orphan drugs, Utilise orphan drug legislation to support commercial development programs
Customers who bought this item also bought
Orphan Disease Series - Glaucoma: Can Orphan-Drug Status Offer an Entry into a Mature Market?
Biomarkers, Tests and Trends for Drug R&D
Biomarkers and Tests for Pharma/ Biotech R&D – Companies Products and WW Market, 2006-2011
Drug Delivery Partnering Terms and Agreements in Pharma and Biotech 2nd Edition
Stem Cells in Regenerative Medicine: Benchmarking Analysis of Big Companies Entering the Market
Taking Advantage of Protein-Based Therapy Opportunities
Systems Biology in Biotech and Pharma: A New Paradigm for Innovation
Prescription Drugs: Global Outlook to 2008
Personalized Medicine: Companies, Trends and World Market
Global Market: Biopharmaceuticals Market Trends & Competition
|
|
|
|
